Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of dried blood spot sampling for nilotinib therapeutic drug monitoring
NL-OMON37855Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nilotinib in chronic myelogenous leukemia (CML), sponsored by Vrije University Medical Center. Primary endpoints: Difference between specimens across blood sampling methods and Difference between duplicate specimens for the same blood sampling method. Started Feb 2013; status: active, not recruiting.
02
Drugs
nilotinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NL-OMON37855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37855.